American Heart Journal
Volume 151, Issue 4 , Pages 757-761 , April 2006

Cardiac resynchronization therapy: A regulatory perspective

  • Warren K. Laskey, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, University of New Mexico School of Medicine, Albuquerque, NM
    • Corresponding Author InformationReprint requests: Warren K. Laskey, MD, Division of Cardiology, Department of Medicine, MSC10-5550, 1 University of New Mexico, Albuquerque, NM 87131-0001.
    • ,
  • William H. Maisel, MD, MPH

      Affiliations

    • Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

Received 20 April 2005 ,Accepted 17 May 2005.

References 

  1. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmias. N Engl J Med. 1996;335:1933–1940
  2. Buxton AE, Lee KL, Josephson ME, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341:1882–1890
  3. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–883
  4. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–237
  5. McAlister FA, Ezekowitz JA, Wiebe N, et al. Systematic review: cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med. 2004;141:381–390
  6. Linde C, Braunschweig F, Gadler F, et al. Long term improvements in quality of life by biventricular pacing in patients with chronic heart failure: results from the Multi-site Stimulation in Cardiomyopathy study (MUSTIC). Am J Cardiol. 2003;91:1090–1099
  7. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced heart failure. N Engl J Med. 2004;350:2140–2150
  8. Nelson GS, Berger RD, Fetics BJ, et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle branch block. Circulation. 2000;102:3053–3059
  9. Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the Multisite Stimulation In Cardiomyopathy (MUSTIC) study. J Am Coll Cardiol. 2002;40:111–118
  10. St John Sutton MG, Plapper T, Abraham WT, et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation. 2003;107:1985–1990
  11. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of survival with heart failure. N Engl J Med. 2002;347:1397–1402
  12. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001–2007
  13. U.S. Food and Drug Administration Center for Devices and Radiological Health. Premarket Approval Application Filign Review-Guidance for Industry and FDA Staff. Available at http://www.fda.gov/cdrh/ode [Assessed May 13, 2005].
  14. Hay I, Melenovksy V, Fetics BJ, et al. Short-term effects of right-left heart sequential cardiac resynchronization in patients with heart failure, chronic atrial fibrillation and atrioventricular nodal block. Circulation. 2004;110:3404–3410
  15. Abraham WT, Young JB, Leon AR, et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator and mildly symptomatic chronic heart failure. Circulation. 2004;110:2864–2868
  16. Cleland JGF, Daubert J-C, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539–1549

 Dr. Laskey is the immediate past chairperson and Dr. Maisel is the current chairperson of the Food and Drug Administration Circulatory System Medical Devices Advisory Panel. The opinions expressed in the article are those of the authors and not necessarily those of the Food and Drug Administration.

PII: S0002-8703(05)00526-0

doi: 10.1016/j.ahj.2005.05.023

American Heart Journal
Volume 151, Issue 4 , Pages 757-761 , April 2006

Article Tools